ArcticZymes Technologies ASA

B4V

Company Profile

  • Business description

    ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Germany, Italy, France, and other countries.

  • Contact

    Sykehusveien 23
    Tromso9294
    NOR

    T: +47 77648900

    https://www.arcticzymes.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    53

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,462.6040.900.49%
CAC 407,743.7549.310.64%
DAX 4023,499.32146.630.63%
Dow JONES (US)41,249.38119.07-0.29%
FTSE 1008,554.8023.190.27%
HKSE22,867.7491.820.40%
NASDAQ17,928.920.780.00%
Nikkei 22537,503.33574.701.56%
NZX 50 Index12,605.07138.041.11%
S&P 5005,659.914.03-0.07%
S&P/ASX 2008,231.2039.500.48%
SSE Composite Index3,342.0010.00-0.30%

Market Movers